## ACNB: ACNB Corporation - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.7% in lower entry zone (3.0-6.0%), top quartile (77th pct) cross-sectional ranking. Short-term MRS_5 (2.3%) confirms momentum alignment. Strong momentum (+4.4% 5-day acceleration). Caution: overbought RSI (72).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($49.09)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 14 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 30.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- FMR, LLC: 5.8% (0.0%)
- Blackrock Inc.: 5.8% (-1.4%)
- Vanguard Group Inc: 5.1% (-1.9%)
- Private Capital Mana: 3.3% (+9.9%)
- Dimensional Fund Adv: 3.0% (+2.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +4.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.12 suggests fair value with growth premium. Forward P/E 10.2x stretched relative to 2% growth. Quality metrics strong (margin 24%). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $0.5B |
| Beta | 0.86 |
| 52W Range | $35.70 - $51.87 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.12 |
| Forward P/E | 10.2 |
| Current P/E | 10.4 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.7% to 3.7% (+4.4% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 77th percentile. MRS_5 at 2.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.74% (CS: 78) | Strong |
| RSI_14 | 71.5 | Overbought |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.062x | Above |
| vs SMA50 | 1.113x | Above |
| vs SMA200 | 1.184x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $51.59
- **Stop Loss:** $49.09 (4.8% risk)
- **Target:** $55.34 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 552
- **Position Value:** $28,477.68
- **Portfolio %:** 28.48%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-22 (Est: $1.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.18 | $1.44 | +21.7% |
| 2025Q2 | $1.15 | $1.25 | +8.8% |
| 2025Q1 | $0.93 | $0.79 | -15.0% |
| 2024Q4 | $0.85 | $0.86 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*